GlassScriptPhysician profile
Sunil P Pasricha
NPI 1396850152
$2,220.68
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,594 · 2020: $605 · 2021: $22.05.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $510.94 | 2019-2021 | |
| Abbvie INC. | $392.32 | 2019-2020 | |
| Janssen Biotech, INC. | $193.84 | 2019-2020 | |
| Pfizer INC. | $162.94 | 2019 | |
| Ironwood Pharmaceuticals, INC | $144.59 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $139.92 | 2019-2020 | |
| Qol Medical, LLC | $123.01 | 2019-2020 | |
| Gilead Sciences, INC. | $97.12 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $92.02 | 2020 | |
| Merck Sharp & Dohme LLC | $82.03 | 2019 | |
| Allergan, INC. | $63.63 | 2019-2020 | |
| Concordia Pharmaceuticals INC. | $60.40 | 2019 | |
| Intercept Pharmaceuticals, INC. | $57.27 | 2019-2020 | |
| Daiichi Sankyo INC. | $15.77 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $15.61 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $15.02 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.40 | 2019 | |
| Shire North American Group INC | $13.96 | 2019 | |
| Ethicon US, LLC | $13.17 | 2020 | |
| Ferring Pharmaceuticals INC. | $12.72 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Pasricha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.